Evotec SE (EVO) Other financing activities (2009 - 2026)
Evotec SE's (EVO) quarterly Other financing activities came in at $115903.8 in Q1 2026, down 47.53% year-over-year from $220895.7 in Q1 2025, and up 1322.43% quarter-over-quarter from $8148.3 in Q4 2025.
Analysis
Evotec SE (EVO) Other financing activities (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Other financing activities across 9 years of filings, most recently posting $115903.8 for Q1 2026.
- In Q1 2026, Other financing activities fell 47.53% year-over-year to $115903.8; the TTM figure through Mar 2026 stood at $141186.7 (down 77.4% YoY), while the FY2025 annual figure was $254207.5, down 36.18% from the prior year.
- Other financing activities came in at $115903.8 for Q1 2026 at Evotec SE, up from $8148.3 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $403740.6 in Q3 2024 to a low of -$237470.4 in Q2 2025.
- Average Other financing activities over 5 years is $103396.2, with a median of $8148.3 recorded in 2025.
- The largest YoY upside for Other financing activities was 55608.31% in 2025 against a maximum downside of 7350617.43% in 2025.
- Over 5 years, Other financing activities stood at -$1008.3 in 2022, then plunged by 1393.95% to -$15063.2 in 2023, then surged by 2780.32% to $403740.6 in 2024, then sank by 97.98% to $8148.3 in 2025, then surged by 1322.43% to $115903.8 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $115903.8 in Q1 2026, $8148.3 in Q4 2025, and $254605.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 115,903.82 |
| Dec 31, 2025 | 8,148.30 |
| Sep 30, 2025 | 254,605.00 |
| Jun 30, 2025 | -237,470.43 |
| Mar 31, 2025 | 220,895.73 |
| Sep 30, 2024 | 403,740.63 |
| Jun 30, 2024 | 3.23 |
| Mar 31, 2024 | 396.52 |
| Dec 31, 2023 | -15,063.16 |
| Sep 30, 2022 | -1,008.27 |
| Mar 31, 2022 | 387,206.51 |
| Sep 30, 2021 | 593,181.52 |
| Jun 30, 2021 | 56,600.76 |
| Mar 31, 2021 | 779,228.53 |
| Dec 31, 2019 | 1.88 Mn |
| Sep 30, 2010 | 18,077.82 |
| Jun 30, 2010 | 193,775.30 |
| Mar 31, 2010 | 56,773.10 |
| Dec 31, 2009 | 475,508.42 |
| Mar 31, 2009 | 57,540.28 |